R-pharm
Clinical trials sponsored by R-pharm, explained in plain language.
-
New cancer drug enters final testing phase against standard treatment
Disease control OngoingThis study is testing if a new drug called RPH-002 is as effective and safe as the standard drug Erbitux for treating advanced head and neck cancer that has spread or returned. About 161 patients will receive either RPH-002 or Erbitux along with standard chemotherapy. The goal is…
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for advanced breast cancer? trial tests potential cheaper alternative
Disease control OngoingThis study is testing if a new drug called RPH-051 works as well as the established drug Perjeta (pertuzumab) for controlling advanced HER2-positive breast cancer. About 246 patients with metastatic or locally advanced cancer will receive either RPH-051 or Perjeta, combined with …
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC